Oppenheimer Initiates Coverage on Electro-Optical Sciences (MELA) with an Outperform
More News related to MELA
- Boenning & Scattergood Initiates Coverage on Electro-Optical Sciences (MELA) with an Outperform
- Electro-Optical Sciences to Present at Upcoming Investor Conferences
- Roth Capital Downgrades Electro-Optical Sciences (MELA) to Hold; Valuation Call
- Electro-Optical Sciences Announces Participation at the Oppenheimer 20th Annual Healthcare Conference
- Oppenheimer Initiates Coverage on Electro-Optical Sciences (MELA) with an Outperform
Oppenheimer initiates coverage on Electro-Optical Sciences (Nasdaq: MELA) with an Outperform rating. Price target $11.
To see more analyst ratings on MELA Click Here.
Electro-Optical Sciences, Inc., a medical device company, focuses on the design, development, and commercialization of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma in the United States and internationally
Related Categories
New CoverageStocks Mentioned
+0.73Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
11 dollars try 50 dollars!
Dion Cozamanis on Aug 20, 2009 06:33 PMThis device will be in every medical doctors office.. Its efficiency at detection of melanomas is much greater than anything weve ever seen.. just go to the site and listen to last conference call.. they met every expectation and more that the fda requested and will save millions of people.. I really think a buy out will occur.. this is so cheap with given all the information... wow just research and buy as much as you can !! Motley fool members are giveing it thier blessings also..